Menu Back to DIA-Meeting-on-Combination-Products

Program Committee

  • Jennifer  Paine, MS, RAC
    Jennifer Paine, MS, RAC Executive Vice President, Worldwide Quality, Regulatory and Compliance
    Ortho Clinical Diagnostic, United States
  • Valerie  Fenster
    Valerie Fenster Senior Manager, Human Factors Engineering, Device Technologies
    Amgen Inc., United States
  • Jafar  Shenasa
    Jafar Shenasa Senior Director, Regulatory Affairs
    Proteus Digital Health, Inc., United States
  • Steven B. Binion, PhD, MBA
    Steven B. Binion, PhD, MBA Director - Policy, Technology and Communication, Corporate Regulatory Affairs
    Becton Dickinson, United States
  • Jennifer  Dudinak, PharmD
    Jennifer Dudinak, PharmD Vice President, Global Regulatory Affairs
    GlaxoSmithKline, United States
  • Azin  Shahzamani
    Azin Shahzamani Senior Director, Regulatory Affairs
    Genentech, A Member of the Roche Group, United States
  • Jeffrey N. Stuart, PhD, RAC
    Jeffrey N. Stuart, PhD, RAC Director, Regulatory Affairs
    Novartis Pharmaceuticals Corporation, United States
  • Bradley Merrill Thompson, JD, MBA
    Bradley Merrill Thompson, JD, MBA General Counsel, Combination Products Coalition
    Epstein, Becker and Green P.C., United States
  • John Barlow Weiner, JD
    John Barlow Weiner, JD Associate Director, Policy and Product Classification Officer, OCP, OC
    FDA, United States
Load More